Search results
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the...
WROC Rochester· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Preserving breast tissue outside of body will aid cancer research – study
PA Media: Science via Yahoo News· 7 days ago“However, not all drugs work for all women. This new approach means that we can start to determine...
Former NC GOP leader: State treasurer must reverse course on weight loss drugs | Opinion
Durham Herald-Sun McClatchy via AOL· 16 hours agoBut private insurers and other parties already negotiate bulk prices with drug makers, often...
A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs
Time via Yahoo News· 6 days agoFor now, doctors can order the MyPhenome test for patients from Phenomix’s website and use it as...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via AOL· 3 days agoCHICAGO (Reuters) -A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now...
Integration of pharmacies with physician practices has little impact on cancer drug expenditures,...
Medical Xpress· 2 days agoIn addition, there were no discernible benefits for patients as measured by out-of-pocket expenditures, medication adherence, and the amount of time before treatment of cancer
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Blood test that detects colon cancer close to receiving FDA approval
News 12 New Jersey· 1 day agoA blood test that detects colon cancer is one step closer to being approved by the Food and Drug Administration. The Guardant Shield blood test has been ...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 7 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 6 days ago, opens new tab has been sued by an independent Connecticut laboratory that accused the drugmaker of...